Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-70

It's clearly just a progress update on the Oasis trial notifying the market of the 'first patient dosed' .... clearly some expected too much from a simple announcement and are expressing that on HC after the decline in the share price from the morning sugar hit and a reminder that we are also in the last week of tax loss selling too I might add .... perhaps lower your expectations from some of these announcements and then you may not be so disappointed ?


I do find it amusing that if IMU don't update the market some are not happy and yet when they do update the market those very same people are still not happy 'apparently' all because the share price didn't go to where they wanted / expected it to ?  lol